• Introduction
  • Why Almac?
  • People
  • Facilities
• Biomarker Discovery and Validation
  • Companion Diagnostics
  • Prognostic tests
  • Drug Repositioning
  • Consultancy
• Bioinformatics Solutions
  • Gene Selection
  • Signature generation
  • Functional analysis
• Genomic services
  • Gene Expression and SNP analysis
  • qPCR and cell line modelling
  • Bioinformatics
• Cancer DSA™
  • Unique Content
  • Work with FFPE and fresh frozen tissue
  • Discover Targets, signatures and answers
• Resources
  • Technical Documentation
  • Posters and presentations
  • Publications

DSA™ Technology

We have developed our own range of tools to facilitate the provision of solutions for the oncology market. We focused on characterising the transcriptome of a range of cancer types and from this we developed a focussed microarray for each cancer type.

Our Cancer DSA™ research tools are the first high-density transcriptome based microarrays which focus on the transcriptome of a particular disease. They contain the most comprehensive information available for the disease under investigation on a single array and enable the obtaining of robust data from FFPE and frozen samples, while delivering additional information on the disease setting.

The following DSA™ research tools are now available:

• Prostate Cancer
• Lung Cancer
• Ovarian Cancer
• Breast Cancer
• Colorectal Cancer